author_facet Guardiola, Emmanuel
Delroeux, Delphine
Heyd, Bruno
Combe, Marielle
Lorgis, Veronique
Demarchi, Martin
Stein, Ulrich
Royer, Bernard
Chauffert, Bruno
Pivot, Xavier
Guardiola, Emmanuel
Delroeux, Delphine
Heyd, Bruno
Combe, Marielle
Lorgis, Veronique
Demarchi, Martin
Stein, Ulrich
Royer, Bernard
Chauffert, Bruno
Pivot, Xavier
author Guardiola, Emmanuel
Delroeux, Delphine
Heyd, Bruno
Combe, Marielle
Lorgis, Veronique
Demarchi, Martin
Stein, Ulrich
Royer, Bernard
Chauffert, Bruno
Pivot, Xavier
spellingShingle Guardiola, Emmanuel
Delroeux, Delphine
Heyd, Bruno
Combe, Marielle
Lorgis, Veronique
Demarchi, Martin
Stein, Ulrich
Royer, Bernard
Chauffert, Bruno
Pivot, Xavier
World Journal of Surgical Oncology
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
Oncology
Surgery
author_sort guardiola, emmanuel
spelling Guardiola, Emmanuel Delroeux, Delphine Heyd, Bruno Combe, Marielle Lorgis, Veronique Demarchi, Martin Stein, Ulrich Royer, Bernard Chauffert, Bruno Pivot, Xavier 1477-7819 Springer Science and Business Media LLC Oncology Surgery http://dx.doi.org/10.1186/1477-7819-7-14 <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Intra-peritoneal (i.p.) chemotherapy is an encouraging treatment option for ovarian cancer with peritoneum involvement in addition with intravenous (i.v.) chemotherapy. Intra-operative i.p. chemotherapy is an interesting method of administration by enhancing the diffusion of chemotherapy. This study had assessed the feasibility of intra-operative i.p. chemotherapy in patients with peritoneal carcinoma of ovarian cancer.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>From January 2003 to February 2006, 47 patients with stage III ovarian cancer were treated with standard paclitaxel carboplatin intravenous chemotherapy and debulking surgery with intra-operative i.p. chemotherapy. After optimal cytoreductive surgery, defined by no unresectable residual disease &gt; 1 cm, i.p. chemotherapy was performed during surgery. The peritoneal cavity was filled by 3 litres of isotonic saline pre-heated at 37 degrees and 90 mg of cisplatin. The sequence was repeated twice during 2 hours based on previous published studies which optimized the cisplatin dosage and exposure duration. Optimal diffusion was obtained by stirring by hands during the 2 hours.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Median age was 59.6 years. No severe haematological or non-haematological toxicity induced by intra operative i.p. chemotherapy was reported. No patient died due to the complications of surgery or the i.p. chemotherapy. No neurotoxicity occurred, and one patients had renal impairment.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>This study demonstrates the feasibility of intra-operative i.p. chemotherapy with cisplatin after optimal resection of peritoneal tumor nodules. Further randomized trials are planned to investigate the clinical benefit of this therapeutic modality.</jats:p> </jats:sec> Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer World Journal of Surgical Oncology
doi_str_mv 10.1186/1477-7819-7-14
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc3LTc4MTktNy0xNA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc3LTc4MTktNy0xNA
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Rs1
DE-Pl11
DE-105
DE-14
DE-Ch1
DE-L229
imprint Springer Science and Business Media LLC, 2009
imprint_str_mv Springer Science and Business Media LLC, 2009
issn 1477-7819
issn_str_mv 1477-7819
language English
mega_collection Springer Science and Business Media LLC (CrossRef)
match_str guardiola2009intraoperativeintraperitonealchemotherapywithcisplatininpatientswithperitonealcarcinomatosisofovariancancer
publishDateSort 2009
publisher Springer Science and Business Media LLC
recordtype ai
record_format ai
series World Journal of Surgical Oncology
source_id 49
title Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_unstemmed Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_full Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_fullStr Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_full_unstemmed Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_short Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_sort intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
topic Oncology
Surgery
url http://dx.doi.org/10.1186/1477-7819-7-14
publishDate 2009
physical
description <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Intra-peritoneal (i.p.) chemotherapy is an encouraging treatment option for ovarian cancer with peritoneum involvement in addition with intravenous (i.v.) chemotherapy. Intra-operative i.p. chemotherapy is an interesting method of administration by enhancing the diffusion of chemotherapy. This study had assessed the feasibility of intra-operative i.p. chemotherapy in patients with peritoneal carcinoma of ovarian cancer.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>From January 2003 to February 2006, 47 patients with stage III ovarian cancer were treated with standard paclitaxel carboplatin intravenous chemotherapy and debulking surgery with intra-operative i.p. chemotherapy. After optimal cytoreductive surgery, defined by no unresectable residual disease &gt; 1 cm, i.p. chemotherapy was performed during surgery. The peritoneal cavity was filled by 3 litres of isotonic saline pre-heated at 37 degrees and 90 mg of cisplatin. The sequence was repeated twice during 2 hours based on previous published studies which optimized the cisplatin dosage and exposure duration. Optimal diffusion was obtained by stirring by hands during the 2 hours.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Median age was 59.6 years. No severe haematological or non-haematological toxicity induced by intra operative i.p. chemotherapy was reported. No patient died due to the complications of surgery or the i.p. chemotherapy. No neurotoxicity occurred, and one patients had renal impairment.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>This study demonstrates the feasibility of intra-operative i.p. chemotherapy with cisplatin after optimal resection of peritoneal tumor nodules. Further randomized trials are planned to investigate the clinical benefit of this therapeutic modality.</jats:p> </jats:sec>
container_issue 1
container_start_page 0
container_title World Journal of Surgical Oncology
container_volume 7
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792332985711722499
geogr_code not assigned
last_indexed 2024-03-01T14:05:34.215Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Intra-operative+intra-peritoneal+chemotherapy+with+cisplatin+in+patients+with+peritoneal+carcinomatosis+of+ovarian+cancer&rft.date=2009-12-01&genre=article&issn=1477-7819&volume=7&issue=1&jtitle=World+Journal+of+Surgical+Oncology&atitle=Intra-operative+intra-peritoneal+chemotherapy+with+cisplatin+in+patients+with+peritoneal+carcinomatosis+of+ovarian+cancer&aulast=Pivot&aufirst=Xavier&rft_id=info%3Adoi%2F10.1186%2F1477-7819-7-14&rft.language%5B0%5D=eng
SOLR
_version_ 1792332985711722499
author Guardiola, Emmanuel, Delroeux, Delphine, Heyd, Bruno, Combe, Marielle, Lorgis, Veronique, Demarchi, Martin, Stein, Ulrich, Royer, Bernard, Chauffert, Bruno, Pivot, Xavier
author_facet Guardiola, Emmanuel, Delroeux, Delphine, Heyd, Bruno, Combe, Marielle, Lorgis, Veronique, Demarchi, Martin, Stein, Ulrich, Royer, Bernard, Chauffert, Bruno, Pivot, Xavier, Guardiola, Emmanuel, Delroeux, Delphine, Heyd, Bruno, Combe, Marielle, Lorgis, Veronique, Demarchi, Martin, Stein, Ulrich, Royer, Bernard, Chauffert, Bruno, Pivot, Xavier
author_sort guardiola, emmanuel
container_issue 1
container_start_page 0
container_title World Journal of Surgical Oncology
container_volume 7
description <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Intra-peritoneal (i.p.) chemotherapy is an encouraging treatment option for ovarian cancer with peritoneum involvement in addition with intravenous (i.v.) chemotherapy. Intra-operative i.p. chemotherapy is an interesting method of administration by enhancing the diffusion of chemotherapy. This study had assessed the feasibility of intra-operative i.p. chemotherapy in patients with peritoneal carcinoma of ovarian cancer.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>From January 2003 to February 2006, 47 patients with stage III ovarian cancer were treated with standard paclitaxel carboplatin intravenous chemotherapy and debulking surgery with intra-operative i.p. chemotherapy. After optimal cytoreductive surgery, defined by no unresectable residual disease &gt; 1 cm, i.p. chemotherapy was performed during surgery. The peritoneal cavity was filled by 3 litres of isotonic saline pre-heated at 37 degrees and 90 mg of cisplatin. The sequence was repeated twice during 2 hours based on previous published studies which optimized the cisplatin dosage and exposure duration. Optimal diffusion was obtained by stirring by hands during the 2 hours.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Median age was 59.6 years. No severe haematological or non-haematological toxicity induced by intra operative i.p. chemotherapy was reported. No patient died due to the complications of surgery or the i.p. chemotherapy. No neurotoxicity occurred, and one patients had renal impairment.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>This study demonstrates the feasibility of intra-operative i.p. chemotherapy with cisplatin after optimal resection of peritoneal tumor nodules. Further randomized trials are planned to investigate the clinical benefit of this therapeutic modality.</jats:p> </jats:sec>
doi_str_mv 10.1186/1477-7819-7-14
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc3LTc4MTktNy0xNA
imprint Springer Science and Business Media LLC, 2009
imprint_str_mv Springer Science and Business Media LLC, 2009
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229
issn 1477-7819
issn_str_mv 1477-7819
language English
last_indexed 2024-03-01T14:05:34.215Z
match_str guardiola2009intraoperativeintraperitonealchemotherapywithcisplatininpatientswithperitonealcarcinomatosisofovariancancer
mega_collection Springer Science and Business Media LLC (CrossRef)
physical
publishDate 2009
publishDateSort 2009
publisher Springer Science and Business Media LLC
record_format ai
recordtype ai
series World Journal of Surgical Oncology
source_id 49
spelling Guardiola, Emmanuel Delroeux, Delphine Heyd, Bruno Combe, Marielle Lorgis, Veronique Demarchi, Martin Stein, Ulrich Royer, Bernard Chauffert, Bruno Pivot, Xavier 1477-7819 Springer Science and Business Media LLC Oncology Surgery http://dx.doi.org/10.1186/1477-7819-7-14 <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Intra-peritoneal (i.p.) chemotherapy is an encouraging treatment option for ovarian cancer with peritoneum involvement in addition with intravenous (i.v.) chemotherapy. Intra-operative i.p. chemotherapy is an interesting method of administration by enhancing the diffusion of chemotherapy. This study had assessed the feasibility of intra-operative i.p. chemotherapy in patients with peritoneal carcinoma of ovarian cancer.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>From January 2003 to February 2006, 47 patients with stage III ovarian cancer were treated with standard paclitaxel carboplatin intravenous chemotherapy and debulking surgery with intra-operative i.p. chemotherapy. After optimal cytoreductive surgery, defined by no unresectable residual disease &gt; 1 cm, i.p. chemotherapy was performed during surgery. The peritoneal cavity was filled by 3 litres of isotonic saline pre-heated at 37 degrees and 90 mg of cisplatin. The sequence was repeated twice during 2 hours based on previous published studies which optimized the cisplatin dosage and exposure duration. Optimal diffusion was obtained by stirring by hands during the 2 hours.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Median age was 59.6 years. No severe haematological or non-haematological toxicity induced by intra operative i.p. chemotherapy was reported. No patient died due to the complications of surgery or the i.p. chemotherapy. No neurotoxicity occurred, and one patients had renal impairment.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>This study demonstrates the feasibility of intra-operative i.p. chemotherapy with cisplatin after optimal resection of peritoneal tumor nodules. Further randomized trials are planned to investigate the clinical benefit of this therapeutic modality.</jats:p> </jats:sec> Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer World Journal of Surgical Oncology
spellingShingle Guardiola, Emmanuel, Delroeux, Delphine, Heyd, Bruno, Combe, Marielle, Lorgis, Veronique, Demarchi, Martin, Stein, Ulrich, Royer, Bernard, Chauffert, Bruno, Pivot, Xavier, World Journal of Surgical Oncology, Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer, Oncology, Surgery
title Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_full Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_fullStr Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_full_unstemmed Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_short Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_sort intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
title_unstemmed Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
topic Oncology, Surgery
url http://dx.doi.org/10.1186/1477-7819-7-14